Yet, their changes are not entirely specific to AD (Lleo et al., 2015), and moreover, it is challenging for the combination of Aβ, T-tau or P-tau in CSF to distinguish early AD to controls (Wood, 2016). The gene discussed is MAPT; the disease is Alzheimer disease.